nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Doxorubicin—sarcoma	0.541	0.728	CbGbCtD
L-Carnitine—SLC22A5—Dactinomycin—sarcoma	0.109	0.146	CbGbCtD
L-Carnitine—XDH—Doxorubicin—sarcoma	0.0933	0.126	CbGbCtD
L-Carnitine—CROT—Vinorelbine—Vincristine—sarcoma	0.00683	1	CbGdCrCtD
L-Carnitine—CES1—larynx—sarcoma	0.00606	0.043	CbGeAlD
L-Carnitine—CROT—mammary gland—sarcoma	0.00509	0.0361	CbGeAlD
L-Carnitine—SLC22A4—larynx—sarcoma	0.00462	0.0328	CbGeAlD
L-Carnitine—XDH—Effects of Nitric Oxide—MB—sarcoma	0.00413	0.342	CbGpPWpGaD
L-Carnitine—SLC25A20—myometrium—sarcoma	0.00314	0.0223	CbGeAlD
L-Carnitine—CRAT—myometrium—sarcoma	0.00305	0.0216	CbGeAlD
L-Carnitine—SLC25A20—seminal vesicle—sarcoma	0.00284	0.0202	CbGeAlD
L-Carnitine—CRAT—seminal vesicle—sarcoma	0.00275	0.0196	CbGeAlD
L-Carnitine—SLC22A16—bone marrow—sarcoma	0.00275	0.0195	CbGeAlD
L-Carnitine—CROT—smooth muscle tissue—sarcoma	0.00273	0.0194	CbGeAlD
L-Carnitine—CROT—skin of body—sarcoma	0.00269	0.0191	CbGeAlD
L-Carnitine—SLC25A20—connective tissue—sarcoma	0.0026	0.0184	CbGeAlD
L-Carnitine—SLC22A16—testis—sarcoma	0.00235	0.0167	CbGeAlD
L-Carnitine—SLC25A20—skin of body—sarcoma	0.00234	0.0167	CbGeAlD
L-Carnitine—CPT2—myometrium—sarcoma	0.00234	0.0167	CbGeAlD
L-Carnitine—CROT—uterus—sarcoma	0.00234	0.0166	CbGeAlD
L-Carnitine—CRAT—smooth muscle tissue—sarcoma	0.0023	0.0164	CbGeAlD
L-Carnitine—CRAT—skin of body—sarcoma	0.00227	0.0162	CbGeAlD
L-Carnitine—CPT1A—hematopoietic system—sarcoma	0.00212	0.0151	CbGeAlD
L-Carnitine—CPT2—seminal vesicle—sarcoma	0.00212	0.015	CbGeAlD
L-Carnitine—CROT—tendon—sarcoma	0.00205	0.0146	CbGeAlD
L-Carnitine—SLC25A20—cardiac atrium—sarcoma	0.00205	0.0145	CbGeAlD
L-Carnitine—CPT1A—connective tissue—sarcoma	0.00204	0.0145	CbGeAlD
L-Carnitine—SLC25A20—uterus—sarcoma	0.00204	0.0145	CbGeAlD
L-Carnitine—MPO—endothelium—sarcoma	0.00203	0.0144	CbGeAlD
L-Carnitine—CPT2—hematopoietic system—sarcoma	0.00201	0.0143	CbGeAlD
L-Carnitine—CROT—bone marrow—sarcoma	0.00199	0.0141	CbGeAlD
L-Carnitine—CRAT—cardiac atrium—sarcoma	0.00199	0.0141	CbGeAlD
L-Carnitine—CRAT—uterus—sarcoma	0.00198	0.014	CbGeAlD
L-Carnitine—CPT2—connective tissue—sarcoma	0.00194	0.0138	CbGeAlD
L-Carnitine—SLC25A29—testis—sarcoma	0.00185	0.0132	CbGeAlD
L-Carnitine—SLC25A20—tendon—sarcoma	0.00178	0.0127	CbGeAlD
L-Carnitine—SLC25A29—liver—sarcoma	0.00175	0.0124	CbGeAlD
L-Carnitine—CPT2—skin of body—sarcoma	0.00175	0.0124	CbGeAlD
L-Carnitine—CRAT—tendon—sarcoma	0.00173	0.0123	CbGeAlD
L-Carnitine—SLC25A20—bone marrow—sarcoma	0.00173	0.0123	CbGeAlD
L-Carnitine—CROT—testis—sarcoma	0.0017	0.0121	CbGeAlD
L-Carnitine—SLCO1B1—mammary gland—sarcoma	0.00169	0.012	CbGeAlD
L-Carnitine—CRAT—bone marrow—sarcoma	0.00168	0.0119	CbGeAlD
L-Carnitine—CROT—liver—sarcoma	0.00161	0.0114	CbGeAlD
L-Carnitine—CPT2—cardiac atrium—sarcoma	0.00153	0.0109	CbGeAlD
L-Carnitine—CPT2—uterus—sarcoma	0.00152	0.0108	CbGeAlD
L-Carnitine—SLC22A4—mammary gland—sarcoma	0.0015	0.0106	CbGeAlD
L-Carnitine—XDH—Effects of Nitric Oxide—HBA1—sarcoma	0.00149	0.123	CbGpPWpGaD
L-Carnitine—SLC25A20—testis—sarcoma	0.00148	0.0105	CbGeAlD
L-Carnitine—CRAT—testis—sarcoma	0.00143	0.0102	CbGeAlD
L-Carnitine—CPT1A—tendon—sarcoma	0.0014	0.00997	CbGeAlD
L-Carnitine—SLC25A20—liver—sarcoma	0.0014	0.00993	CbGeAlD
L-Carnitine—CRAT—liver—sarcoma	0.00136	0.00963	CbGeAlD
L-Carnitine—SLC25A29—lymph node—sarcoma	0.00134	0.00954	CbGeAlD
L-Carnitine—CPT2—tendon—sarcoma	0.00133	0.00946	CbGeAlD
L-Carnitine—CPT2—bone marrow—sarcoma	0.00129	0.00917	CbGeAlD
L-Carnitine—CROT—lymph node—sarcoma	0.00123	0.00875	CbGeAlD
L-Carnitine—CES1—hematopoietic system—sarcoma	0.0012	0.00849	CbGeAlD
L-Carnitine—CPT1A—testis—sarcoma	0.00116	0.00826	CbGeAlD
L-Carnitine—CES1—connective tissue—sarcoma	0.00115	0.00818	CbGeAlD
L-Carnitine—CPT2—testis—sarcoma	0.0011	0.00784	CbGeAlD
L-Carnitine—CPT1A—liver—sarcoma	0.0011	0.00781	CbGeAlD
L-Carnitine—SLC25A20—lymph node—sarcoma	0.00107	0.00761	CbGeAlD
L-Carnitine—SLC22A4—myometrium—sarcoma	0.00106	0.00754	CbGeAlD
L-Carnitine—CPT2—liver—sarcoma	0.00104	0.00741	CbGeAlD
L-Carnitine—CRAT—lymph node—sarcoma	0.00104	0.00738	CbGeAlD
L-Carnitine—SLCO1B1—hematopoietic system—sarcoma	0.00103	0.0073	CbGeAlD
L-Carnitine—MPO—hematopoietic system—sarcoma	0.000998	0.00709	CbGeAlD
L-Carnitine—SLC22A5—mammary gland—sarcoma	0.00099	0.00703	CbGeAlD
L-Carnitine—MPO—connective tissue—sarcoma	0.000961	0.00683	CbGeAlD
L-Carnitine—SLC22A4—seminal vesicle—sarcoma	0.000959	0.00681	CbGeAlD
L-Carnitine—MPO—skin of body—sarcoma	0.000868	0.00617	CbGeAlD
L-Carnitine—CPT1A—lymph node—sarcoma	0.000842	0.00598	CbGeAlD
L-Carnitine—CES1—lymphoid tissue—sarcoma	0.000841	0.00598	CbGeAlD
L-Carnitine—XDH—liver—sarcoma	0.000812	0.00577	CbGeAlD
L-Carnitine—CPT2—lymph node—sarcoma	0.000799	0.00568	CbGeAlD
L-Carnitine—SLC22A8—hematopoietic system—sarcoma	0.000798	0.00567	CbGeAlD
L-Carnitine—MPO—lymphoid tissue—sarcoma	0.000703	0.00499	CbGeAlD
L-Carnitine—SLC22A5—myometrium—sarcoma	0.000702	0.00499	CbGeAlD
L-Carnitine—CES1—testis—sarcoma	0.000655	0.00465	CbGeAlD
L-Carnitine—MPO—bone marrow—sarcoma	0.00064	0.00455	CbGeAlD
L-Carnitine—SLC22A5—seminal vesicle—sarcoma	0.000635	0.00451	CbGeAlD
L-Carnitine—CES1—liver—sarcoma	0.000619	0.0044	CbGeAlD
L-Carnitine—SLC22A4—tendon—sarcoma	0.000603	0.00429	CbGeAlD
L-Carnitine—SLC22A4—bone marrow—sarcoma	0.000584	0.00415	CbGeAlD
L-Carnitine—MPO—testis—sarcoma	0.000547	0.00389	CbGeAlD
L-Carnitine—SLCO1B1—liver—sarcoma	0.000532	0.00378	CbGeAlD
L-Carnitine—SLC22A5—skin of body—sarcoma	0.000524	0.00373	CbGeAlD
L-Carnitine—MPO—liver—sarcoma	0.000517	0.00367	CbGeAlD
L-Carnitine—CES1—lymph node—sarcoma	0.000475	0.00337	CbGeAlD
L-Carnitine—Back pain—Vincristine—sarcoma	0.00047	0.00485	CcSEcCtD
L-Carnitine—Myalgia—Thiotepa—sarcoma	0.000466	0.00481	CcSEcCtD
L-Carnitine—Anxiety—Thiotepa—sarcoma	0.000465	0.0048	CcSEcCtD
L-Carnitine—Injection site reaction—Doxorubicin—sarcoma	0.000464	0.00479	CcSEcCtD
L-Carnitine—CES1—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000464	0.0384	CbGpPWpGaD
L-Carnitine—Cramps of lower extremities—Epirubicin—sarcoma	0.000463	0.00478	CcSEcCtD
L-Carnitine—Dysgeusia—Mitoxantrone—sarcoma	0.000463	0.00478	CcSEcCtD
L-Carnitine—Myalgia—Dactinomycin—sarcoma	0.000463	0.00478	CcSEcCtD
L-Carnitine—Hyperkalaemia—Doxorubicin—sarcoma	0.000459	0.00473	CcSEcCtD
L-Carnitine—SLC22A5—cardiac atrium—sarcoma	0.000458	0.00325	CbGeAlD
L-Carnitine—Back pain—Mitoxantrone—sarcoma	0.000457	0.00472	CcSEcCtD
L-Carnitine—Melaena—Doxorubicin—sarcoma	0.000456	0.00471	CcSEcCtD
L-Carnitine—Anaemia—Vincristine—sarcoma	0.000449	0.00463	CcSEcCtD
L-Carnitine—Infection—Thiotepa—sarcoma	0.000444	0.00458	CcSEcCtD
L-Carnitine—Hypertonia—Epirubicin—sarcoma	0.000442	0.00457	CcSEcCtD
L-Carnitine—Infection—Dactinomycin—sarcoma	0.000441	0.00455	CcSEcCtD
L-Carnitine—Anaemia—Mitoxantrone—sarcoma	0.000437	0.00451	CcSEcCtD
L-Carnitine—Vertigo—Vincristine—sarcoma	0.000436	0.00451	CcSEcCtD
L-Carnitine—Tachycardia—Thiotepa—sarcoma	0.000436	0.0045	CcSEcCtD
L-Carnitine—Cramps of lower extremities—Doxorubicin—sarcoma	0.000429	0.00443	CcSEcCtD
L-Carnitine—Anorexia—Thiotepa—sarcoma	0.000426	0.0044	CcSEcCtD
L-Carnitine—Anorexia—Dactinomycin—sarcoma	0.000423	0.00437	CcSEcCtD
L-Carnitine—Eye disorder—Etoposide—sarcoma	0.000422	0.00436	CcSEcCtD
L-Carnitine—Convulsion—Vincristine—sarcoma	0.000421	0.00434	CcSEcCtD
L-Carnitine—Hypertension—Vincristine—sarcoma	0.000419	0.00433	CcSEcCtD
L-Carnitine—Myalgia—Vincristine—sarcoma	0.000413	0.00427	CcSEcCtD
L-Carnitine—Cough—Mitoxantrone—sarcoma	0.000413	0.00426	CcSEcCtD
L-Carnitine—Angiopathy—Etoposide—sarcoma	0.00041	0.00423	CcSEcCtD
L-Carnitine—Convulsion—Mitoxantrone—sarcoma	0.00041	0.00423	CcSEcCtD
L-Carnitine—Hypertonia—Doxorubicin—sarcoma	0.000409	0.00422	CcSEcCtD
L-Carnitine—Hypertension—Mitoxantrone—sarcoma	0.000408	0.00422	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000407	0.0042	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000404	0.00417	CcSEcCtD
L-Carnitine—Chest pain—Mitoxantrone—sarcoma	0.000403	0.00416	CcSEcCtD
L-Carnitine—Myalgia—Mitoxantrone—sarcoma	0.000403	0.00416	CcSEcCtD
L-Carnitine—Paraesthesia—Thiotepa—sarcoma	0.000401	0.00414	CcSEcCtD
L-Carnitine—Anxiety—Mitoxantrone—sarcoma	0.000401	0.00414	CcSEcCtD
L-Carnitine—CPT2—PPAR Alpha Pathway—CCND1—sarcoma	0.0004	0.0331	CbGpPWpGaD
L-Carnitine—SLC22A5—tendon—sarcoma	0.000399	0.00284	CbGeAlD
L-Carnitine—MPO—lymph node—sarcoma	0.000396	0.00282	CbGeAlD
L-Carnitine—Infection—Vincristine—sarcoma	0.000394	0.00407	CcSEcCtD
L-Carnitine—Dyspepsia—Thiotepa—sarcoma	0.000393	0.00406	CcSEcCtD
L-Carnitine—Decreased appetite—Thiotepa—sarcoma	0.000388	0.00401	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—HBA1—sarcoma	0.000387	0.0321	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000386	0.00398	CcSEcCtD
L-Carnitine—Decreased appetite—Dactinomycin—sarcoma	0.000386	0.00398	CcSEcCtD
L-Carnitine—Dysgeusia—Etoposide—sarcoma	0.000385	0.00398	CcSEcCtD
L-Carnitine—Infection—Mitoxantrone—sarcoma	0.000383	0.00396	CcSEcCtD
L-Carnitine—Constipation—Thiotepa—sarcoma	0.000382	0.00395	CcSEcCtD
L-Carnitine—Pain—Thiotepa—sarcoma	0.000382	0.00395	CcSEcCtD
L-Carnitine—Back pain—Etoposide—sarcoma	0.00038	0.00393	CcSEcCtD
L-Carnitine—Pain—Dactinomycin—sarcoma	0.000379	0.00392	CcSEcCtD
L-Carnitine—Muscle spasms—Etoposide—sarcoma	0.000378	0.00391	CcSEcCtD
L-Carnitine—Anorexia—Vincristine—sarcoma	0.000378	0.0039	CcSEcCtD
L-Carnitine—Tachycardia—Mitoxantrone—sarcoma	0.000377	0.00389	CcSEcCtD
L-Carnitine—Hypotension—Vincristine—sarcoma	0.00037	0.00382	CcSEcCtD
L-Carnitine—Anorexia—Mitoxantrone—sarcoma	0.000368	0.0038	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Thiotepa—sarcoma	0.000365	0.00377	CcSEcCtD
L-Carnitine—Anaemia—Etoposide—sarcoma	0.000364	0.00375	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000363	0.00375	CcSEcCtD
L-Carnitine—SLC22A4—lymph node—sarcoma	0.000362	0.00257	CbGeAlD
L-Carnitine—Musculoskeletal discomfort—Vincristine—sarcoma	0.000361	0.00373	CcSEcCtD
L-Carnitine—Hypotension—Mitoxantrone—sarcoma	0.000361	0.00372	CcSEcCtD
L-Carnitine—Insomnia—Vincristine—sarcoma	0.000358	0.0037	CcSEcCtD
L-Carnitine—Paraesthesia—Vincristine—sarcoma	0.000356	0.00367	CcSEcCtD
L-Carnitine—Vertigo—Etoposide—sarcoma	0.000353	0.00365	CcSEcCtD
L-Carnitine—Body temperature increased—Thiotepa—sarcoma	0.000353	0.00365	CcSEcCtD
L-Carnitine—Abdominal pain—Thiotepa—sarcoma	0.000353	0.00365	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000352	0.00363	CcSEcCtD
L-Carnitine—Body temperature increased—Dactinomycin—sarcoma	0.000351	0.00362	CcSEcCtD
L-Carnitine—Abdominal pain—Dactinomycin—sarcoma	0.000351	0.00362	CcSEcCtD
L-Carnitine—Paraesthesia—Mitoxantrone—sarcoma	0.000347	0.00358	CcSEcCtD
L-Carnitine—Decreased appetite—Vincristine—sarcoma	0.000344	0.00356	CcSEcCtD
L-Carnitine—Dyspnoea—Mitoxantrone—sarcoma	0.000344	0.00355	CcSEcCtD
L-Carnitine—Cough—Etoposide—sarcoma	0.000343	0.00354	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Vincristine—sarcoma	0.000342	0.00353	CcSEcCtD
L-Carnitine—Convulsion—Etoposide—sarcoma	0.000341	0.00352	CcSEcCtD
L-Carnitine—Dyspepsia—Mitoxantrone—sarcoma	0.00034	0.00351	CcSEcCtD
L-Carnitine—Hypertension—Etoposide—sarcoma	0.00034	0.00351	CcSEcCtD
L-Carnitine—Constipation—Vincristine—sarcoma	0.000339	0.0035	CcSEcCtD
L-Carnitine—Pain—Vincristine—sarcoma	0.000339	0.0035	CcSEcCtD
L-Carnitine—Decreased appetite—Mitoxantrone—sarcoma	0.000335	0.00346	CcSEcCtD
L-Carnitine—Chest pain—Etoposide—sarcoma	0.000335	0.00346	CcSEcCtD
L-Carnitine—SLC22A5—testis—sarcoma	0.00033	0.00235	CbGeAlD
L-Carnitine—Constipation—Mitoxantrone—sarcoma	0.00033	0.00341	CcSEcCtD
L-Carnitine—Pain—Mitoxantrone—sarcoma	0.00033	0.00341	CcSEcCtD
L-Carnitine—Hypersensitivity—Thiotepa—sarcoma	0.000329	0.0034	CcSEcCtD
L-Carnitine—Hypersensitivity—Dactinomycin—sarcoma	0.000327	0.00337	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Vincristine—sarcoma	0.000324	0.00335	CcSEcCtD
L-Carnitine—Gastritis—Epirubicin—sarcoma	0.000324	0.00335	CcSEcCtD
L-Carnitine—Muscular weakness—Epirubicin—sarcoma	0.000323	0.00333	CcSEcCtD
L-Carnitine—CPT2—PPAR Alpha Pathway—MYC—sarcoma	0.000321	0.0266	CbGpPWpGaD
L-Carnitine—Asthenia—Thiotepa—sarcoma	0.000321	0.00331	CcSEcCtD
L-Carnitine—Infection—Etoposide—sarcoma	0.000319	0.00329	CcSEcCtD
L-Carnitine—Asthenia—Dactinomycin—sarcoma	0.000318	0.00329	CcSEcCtD
L-Carnitine—Influenza—Epirubicin—sarcoma	0.000316	0.00327	CcSEcCtD
L-Carnitine—Pruritus—Thiotepa—sarcoma	0.000316	0.00327	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000316	0.00326	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—HBA1—sarcoma	0.000315	0.0261	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—MYOD1—sarcoma	0.000314	0.026	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CD34—sarcoma	0.000314	0.026	CbGpPWpGaD
L-Carnitine—Tachycardia—Etoposide—sarcoma	0.000313	0.00324	CcSEcCtD
L-Carnitine—Abdominal pain—Vincristine—sarcoma	0.000313	0.00324	CcSEcCtD
L-Carnitine—Body temperature increased—Vincristine—sarcoma	0.000313	0.00324	CcSEcCtD
L-Carnitine—SLC22A5—liver—sarcoma	0.000312	0.00222	CbGeAlD
L-Carnitine—Anorexia—Etoposide—sarcoma	0.000306	0.00316	CcSEcCtD
L-Carnitine—Diarrhoea—Thiotepa—sarcoma	0.000306	0.00316	CcSEcCtD
L-Carnitine—Abdominal pain—Mitoxantrone—sarcoma	0.000305	0.00315	CcSEcCtD
L-Carnitine—Body temperature increased—Mitoxantrone—sarcoma	0.000305	0.00315	CcSEcCtD
L-Carnitine—Bronchitis—Epirubicin—sarcoma	0.000304	0.00314	CcSEcCtD
L-Carnitine—Diarrhoea—Dactinomycin—sarcoma	0.000303	0.00313	CcSEcCtD
L-Carnitine—Hypotension—Etoposide—sarcoma	0.0003	0.0031	CcSEcCtD
L-Carnitine—Gastritis—Doxorubicin—sarcoma	0.0003	0.0031	CcSEcCtD
L-Carnitine—Muscular weakness—Doxorubicin—sarcoma	0.000299	0.00309	CcSEcCtD
L-Carnitine—Dizziness—Thiotepa—sarcoma	0.000296	0.00305	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—sarcoma	0.000293	0.00302	CcSEcCtD
L-Carnitine—Hypersensitivity—Vincristine—sarcoma	0.000292	0.00302	CcSEcCtD
L-Carnitine—Paraesthesia—Etoposide—sarcoma	0.000288	0.00298	CcSEcCtD
L-Carnitine—Weight increased—Epirubicin—sarcoma	0.000288	0.00297	CcSEcCtD
L-Carnitine—Weight decreased—Epirubicin—sarcoma	0.000286	0.00296	CcSEcCtD
L-Carnitine—Dyspnoea—Etoposide—sarcoma	0.000286	0.00296	CcSEcCtD
L-Carnitine—Hypersensitivity—Mitoxantrone—sarcoma	0.000284	0.00294	CcSEcCtD
L-Carnitine—Asthenia—Vincristine—sarcoma	0.000284	0.00294	CcSEcCtD
L-Carnitine—Vomiting—Thiotepa—sarcoma	0.000284	0.00293	CcSEcCtD
L-Carnitine—Vomiting—Dactinomycin—sarcoma	0.000282	0.00291	CcSEcCtD
L-Carnitine—Rash—Thiotepa—sarcoma	0.000282	0.00291	CcSEcCtD
L-Carnitine—Bronchitis—Doxorubicin—sarcoma	0.000282	0.00291	CcSEcCtD
L-Carnitine—Dermatitis—Thiotepa—sarcoma	0.000282	0.00291	CcSEcCtD
L-Carnitine—Headache—Thiotepa—sarcoma	0.00028	0.00289	CcSEcCtD
L-Carnitine—Rash—Dactinomycin—sarcoma	0.00028	0.00289	CcSEcCtD
L-Carnitine—Decreased appetite—Etoposide—sarcoma	0.000279	0.00288	CcSEcCtD
L-Carnitine—CPT1A—PPAR Alpha Pathway—CCND1—sarcoma	0.000277	0.023	CbGpPWpGaD
L-Carnitine—Renal failure—Epirubicin—sarcoma	0.000277	0.00286	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Etoposide—sarcoma	0.000277	0.00286	CcSEcCtD
L-Carnitine—Asthenia—Mitoxantrone—sarcoma	0.000277	0.00286	CcSEcCtD
L-Carnitine—Constipation—Etoposide—sarcoma	0.000275	0.00283	CcSEcCtD
L-Carnitine—Pain—Etoposide—sarcoma	0.000275	0.00283	CcSEcCtD
L-Carnitine—Urinary tract infection—Epirubicin—sarcoma	0.000274	0.00283	CcSEcCtD
L-Carnitine—Diarrhoea—Vincristine—sarcoma	0.000271	0.0028	CcSEcCtD
L-Carnitine—Weight increased—Doxorubicin—sarcoma	0.000266	0.00275	CcSEcCtD
L-Carnitine—Nausea—Thiotepa—sarcoma	0.000265	0.00274	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—sarcoma	0.000265	0.00274	CcSEcCtD
L-Carnitine—Sinusitis—Epirubicin—sarcoma	0.000265	0.00273	CcSEcCtD
L-Carnitine—Diarrhoea—Mitoxantrone—sarcoma	0.000264	0.00273	CcSEcCtD
L-Carnitine—Nausea—Dactinomycin—sarcoma	0.000263	0.00272	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Etoposide—sarcoma	0.000263	0.00271	CcSEcCtD
L-Carnitine—Dizziness—Vincristine—sarcoma	0.000262	0.00271	CcSEcCtD
L-Carnitine—Renal failure—Doxorubicin—sarcoma	0.000257	0.00265	CcSEcCtD
L-Carnitine—Haemoglobin—Epirubicin—sarcoma	0.000255	0.00263	CcSEcCtD
L-Carnitine—Rhinitis—Epirubicin—sarcoma	0.000254	0.00262	CcSEcCtD
L-Carnitine—Abdominal pain—Etoposide—sarcoma	0.000254	0.00262	CcSEcCtD
L-Carnitine—Body temperature increased—Etoposide—sarcoma	0.000254	0.00262	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—sarcoma	0.000254	0.00262	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—sarcoma	0.000253	0.00262	CcSEcCtD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.000253	0.0209	CbGpPWpGaD
L-Carnitine—Vomiting—Vincristine—sarcoma	0.000252	0.0026	CcSEcCtD
L-Carnitine—Pharyngitis—Epirubicin—sarcoma	0.000251	0.0026	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—HBA1—sarcoma	0.00025	0.0207	CbGpPWpGaD
L-Carnitine—Rash—Vincristine—sarcoma	0.00025	0.00258	CcSEcCtD
L-Carnitine—Dermatitis—Vincristine—sarcoma	0.00025	0.00258	CcSEcCtD
L-Carnitine—Oedema peripheral—Epirubicin—sarcoma	0.00025	0.00258	CcSEcCtD
L-Carnitine—Headache—Vincristine—sarcoma	0.000248	0.00256	CcSEcCtD
L-Carnitine—Vomiting—Mitoxantrone—sarcoma	0.000245	0.00253	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—sarcoma	0.000245	0.00253	CcSEcCtD
L-Carnitine—Rash—Mitoxantrone—sarcoma	0.000243	0.00251	CcSEcCtD
L-Carnitine—Dermatitis—Mitoxantrone—sarcoma	0.000243	0.00251	CcSEcCtD
L-Carnitine—Headache—Mitoxantrone—sarcoma	0.000242	0.0025	CcSEcCtD
L-Carnitine—SLC22A5—lymph node—sarcoma	0.00024	0.0017	CbGeAlD
L-Carnitine—Eye disorder—Epirubicin—sarcoma	0.000237	0.00244	CcSEcCtD
L-Carnitine—Hypersensitivity—Etoposide—sarcoma	0.000237	0.00244	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—sarcoma	0.000236	0.00243	CcSEcCtD
L-Carnitine—Nausea—Vincristine—sarcoma	0.000235	0.00243	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—sarcoma	0.000235	0.00243	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—sarcoma	0.000234	0.00242	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—sarcoma	0.000233	0.0024	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—sarcoma	0.000231	0.00238	CcSEcCtD
L-Carnitine—Asthenia—Etoposide—sarcoma	0.00023	0.00238	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—sarcoma	0.00023	0.00237	CcSEcCtD
L-Carnitine—Nausea—Mitoxantrone—sarcoma	0.000229	0.00237	CcSEcCtD
L-Carnitine—Pruritus—Etoposide—sarcoma	0.000227	0.00235	CcSEcCtD
L-Carnitine—Arrhythmia—Epirubicin—sarcoma	0.000226	0.00234	CcSEcCtD
L-Carnitine—CPT1A—PPAR Alpha Pathway—MYC—sarcoma	0.000223	0.0184	CbGpPWpGaD
L-Carnitine—Diarrhoea—Etoposide—sarcoma	0.00022	0.00227	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—sarcoma	0.000219	0.00226	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—HBA1—sarcoma	0.000219	0.0181	CbGpPWpGaD
L-Carnitine—Dysgeusia—Epirubicin—sarcoma	0.000216	0.00223	CcSEcCtD
L-Carnitine—Back pain—Epirubicin—sarcoma	0.000213	0.0022	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—sarcoma	0.000213	0.0022	CcSEcCtD
L-Carnitine—Dizziness—Etoposide—sarcoma	0.000212	0.00219	CcSEcCtD
L-Carnitine—Muscle spasms—Epirubicin—sarcoma	0.000212	0.00219	CcSEcCtD
L-Carnitine—CPT1A—Circadian Clock—CREB1—sarcoma	0.000211	0.0175	CbGpPWpGaD
L-Carnitine—Arrhythmia—Doxorubicin—sarcoma	0.000209	0.00216	CcSEcCtD
L-Carnitine—Vomiting—Etoposide—sarcoma	0.000204	0.00211	CcSEcCtD
L-Carnitine—Anaemia—Epirubicin—sarcoma	0.000204	0.0021	CcSEcCtD
L-Carnitine—Rash—Etoposide—sarcoma	0.000202	0.00209	CcSEcCtD
L-Carnitine—Dermatitis—Etoposide—sarcoma	0.000202	0.00209	CcSEcCtD
L-Carnitine—Headache—Etoposide—sarcoma	0.000201	0.00208	CcSEcCtD
L-Carnitine—Dysgeusia—Doxorubicin—sarcoma	0.0002	0.00206	CcSEcCtD
L-Carnitine—Vertigo—Epirubicin—sarcoma	0.000198	0.00205	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—sarcoma	0.000197	0.00204	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—sarcoma	0.000196	0.00203	CcSEcCtD
L-Carnitine—Palpitations—Epirubicin—sarcoma	0.000195	0.00201	CcSEcCtD
L-Carnitine—Cough—Epirubicin—sarcoma	0.000192	0.00199	CcSEcCtD
L-Carnitine—Convulsion—Epirubicin—sarcoma	0.000191	0.00197	CcSEcCtD
L-Carnitine—Nausea—Etoposide—sarcoma	0.000191	0.00197	CcSEcCtD
L-Carnitine—Hypertension—Epirubicin—sarcoma	0.00019	0.00197	CcSEcCtD
L-Carnitine—Anaemia—Doxorubicin—sarcoma	0.000189	0.00195	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—sarcoma	0.000188	0.00194	CcSEcCtD
L-Carnitine—Chest pain—Epirubicin—sarcoma	0.000188	0.00194	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—sarcoma	0.000187	0.00193	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—sarcoma	0.000183	0.00189	CcSEcCtD
L-Carnitine—Palpitations—Doxorubicin—sarcoma	0.00018	0.00186	CcSEcCtD
L-Carnitine—Infection—Epirubicin—sarcoma	0.000179	0.00185	CcSEcCtD
L-Carnitine—Cough—Doxorubicin—sarcoma	0.000178	0.00184	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—sarcoma	0.000177	0.00183	CcSEcCtD
L-Carnitine—Hypertension—Doxorubicin—sarcoma	0.000176	0.00182	CcSEcCtD
L-Carnitine—Tachycardia—Epirubicin—sarcoma	0.000176	0.00181	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—sarcoma	0.000174	0.00179	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—sarcoma	0.000174	0.00179	CcSEcCtD
L-Carnitine—Anxiety—Doxorubicin—sarcoma	0.000173	0.00179	CcSEcCtD
L-Carnitine—Anorexia—Epirubicin—sarcoma	0.000172	0.00177	CcSEcCtD
L-Carnitine—Hypotension—Epirubicin—sarcoma	0.000168	0.00174	CcSEcCtD
L-Carnitine—Infection—Doxorubicin—sarcoma	0.000165	0.00171	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000164	0.00169	CcSEcCtD
L-Carnitine—Insomnia—Epirubicin—sarcoma	0.000163	0.00168	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—IL2—sarcoma	0.000163	0.0135	CbGpPWpGaD
L-Carnitine—Tachycardia—Doxorubicin—sarcoma	0.000163	0.00168	CcSEcCtD
L-Carnitine—Paraesthesia—Epirubicin—sarcoma	0.000162	0.00167	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—sarcoma	0.00016	0.00166	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—sarcoma	0.000159	0.00164	CcSEcCtD
L-Carnitine—Dyspepsia—Epirubicin—sarcoma	0.000158	0.00164	CcSEcCtD
L-Carnitine—Decreased appetite—Epirubicin—sarcoma	0.000156	0.00162	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—sarcoma	0.000156	0.00161	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000155	0.0016	CcSEcCtD
L-Carnitine—Constipation—Epirubicin—sarcoma	0.000154	0.00159	CcSEcCtD
L-Carnitine—Pain—Epirubicin—sarcoma	0.000154	0.00159	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000152	0.00157	CcSEcCtD
L-Carnitine—Insomnia—Doxorubicin—sarcoma	0.000151	0.00156	CcSEcCtD
L-Carnitine—Paraesthesia—Doxorubicin—sarcoma	0.00015	0.00154	CcSEcCtD
L-Carnitine—Dyspnoea—Doxorubicin—sarcoma	0.000148	0.00153	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Epirubicin—sarcoma	0.000147	0.00152	CcSEcCtD
L-Carnitine—Dyspepsia—Doxorubicin—sarcoma	0.000147	0.00151	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—sarcoma	0.000145	0.00149	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000144	0.00148	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—sarcoma	0.000142	0.00147	CcSEcCtD
L-Carnitine—Constipation—Doxorubicin—sarcoma	0.000142	0.00147	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—sarcoma	0.000142	0.00147	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—sarcoma	0.000142	0.00147	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000136	0.00141	CcSEcCtD
L-Carnitine—Hypersensitivity—Epirubicin—sarcoma	0.000133	0.00137	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—sarcoma	0.000132	0.00136	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—sarcoma	0.000132	0.00136	CcSEcCtD
L-Carnitine—Asthenia—Epirubicin—sarcoma	0.000129	0.00133	CcSEcCtD
L-Carnitine—Pruritus—Epirubicin—sarcoma	0.000127	0.00131	CcSEcCtD
L-Carnitine—Diarrhoea—Epirubicin—sarcoma	0.000123	0.00127	CcSEcCtD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—sarcoma	0.000123	0.0102	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Doxorubicin—sarcoma	0.000123	0.00127	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—KIT—sarcoma	0.00012	0.00993	CbGpPWpGaD
L-Carnitine—Asthenia—Doxorubicin—sarcoma	0.000119	0.00123	CcSEcCtD
L-Carnitine—Dizziness—Epirubicin—sarcoma	0.000119	0.00123	CcSEcCtD
L-Carnitine—Pruritus—Doxorubicin—sarcoma	0.000118	0.00122	CcSEcCtD
L-Carnitine—Vomiting—Epirubicin—sarcoma	0.000114	0.00118	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—sarcoma	0.000114	0.00118	CcSEcCtD
L-Carnitine—Rash—Epirubicin—sarcoma	0.000113	0.00117	CcSEcCtD
L-Carnitine—Dermatitis—Epirubicin—sarcoma	0.000113	0.00117	CcSEcCtD
L-Carnitine—Headache—Epirubicin—sarcoma	0.000113	0.00116	CcSEcCtD
L-Carnitine—Dizziness—Doxorubicin—sarcoma	0.00011	0.00114	CcSEcCtD
L-Carnitine—Nausea—Epirubicin—sarcoma	0.000107	0.0011	CcSEcCtD
L-Carnitine—Vomiting—Doxorubicin—sarcoma	0.000106	0.00109	CcSEcCtD
L-Carnitine—Rash—Doxorubicin—sarcoma	0.000105	0.00108	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—sarcoma	0.000105	0.00108	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—sarcoma	0.000104	0.00108	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL2—sarcoma	0.000102	0.00847	CbGpPWpGaD
L-Carnitine—Nausea—Doxorubicin—sarcoma	9.89e-05	0.00102	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CREB1—sarcoma	9.18e-05	0.0076	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—ENO2—sarcoma	8.76e-05	0.00725	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—HBA1—sarcoma	8.7e-05	0.0072	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—TP53—sarcoma	8.37e-05	0.00693	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CCND1—sarcoma	8.23e-05	0.00681	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—MYC—sarcoma	7.94e-05	0.00657	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—CREB1—sarcoma	7.5e-05	0.0062	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ENO2—sarcoma	7.45e-05	0.00616	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ENO2—sarcoma	7.45e-05	0.00616	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PLCG1—sarcoma	7.43e-05	0.00615	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—HBA1—sarcoma	7.4e-05	0.00612	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—HBA1—sarcoma	7.4e-05	0.00612	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—NRAS—sarcoma	7.09e-05	0.00586	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—JUN—sarcoma	6.6e-05	0.00546	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—sarcoma	6.6e-05	0.00546	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—sarcoma	6.57e-05	0.00544	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	6.55e-05	0.00542	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PLCG1—sarcoma	6.32e-05	0.00523	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PLCG1—sarcoma	6.32e-05	0.00523	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—KRAS—sarcoma	6.1e-05	0.00505	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—sarcoma	5.77e-05	0.00477	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—JUN—sarcoma	5.39e-05	0.00446	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—HRAS—sarcoma	5.18e-05	0.00429	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ENO2—sarcoma	4.8e-05	0.00397	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—HBA1—sarcoma	4.77e-05	0.00395	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PLCG1—sarcoma	4.07e-05	0.00337	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—sarcoma	3.56e-05	0.00295	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ENO2—sarcoma	3.33e-05	0.00275	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HBA1—sarcoma	3.3e-05	0.00273	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PLCG1—sarcoma	2.82e-05	0.00234	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ENO2—sarcoma	2.2e-05	0.00182	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HBA1—sarcoma	2.19e-05	0.00181	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PLCG1—sarcoma	1.87e-05	0.00155	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ENO2—sarcoma	1.16e-05	0.00096	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HBA1—sarcoma	1.15e-05	0.000954	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PLCG1—sarcoma	9.84e-06	0.000814	CbGpPWpGaD
